Join
Live feed
·
INSIDERFilingvia Quantisnow
KalVista Pharmaceuticals Inc. logo

CHIEF MEDICAL OFFICER Audhya Paul K. converted options into 5,000 shares and sold $31,349 worth of shares (2,336 units at $13.42), increasing direct ownership by 2% to 122,505 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KALV (KalVista Pharmaceuticals Inc.) and more on Quantisnow.